Ratings by Berenberg (Shanshan Xu)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/9/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2023 | Seagen | SGEN | Downgrade | Hold (Buy) |
197.99 (228.74) |
15.53% | Details | |
| 1/30/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2023 | Seagen | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2022 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2021 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Allogene | ALLO | New Coverage | Hold (N/A) |
26.01 (2.30) |
-91.16% | Details | |
| 11/4/2019 | BioNTech | BNTX | New Coverage | Buy (N/A) |
16.52 (101.50) |
514.41% | Details | |
| 3/27/2019 | Merus N.V. | MRUS | New Coverage | Buy (N/A) |
12.49 (90.00) |
620.58% | Details | |
| 3/27/2019 | Immunomedics | IMMU | New Coverage | Buy (N/A) |
17.58 (87.86) |
399.77% | Details | |
| 3/27/2019 | Seattle Genetics | SGEN | New Coverage | Buy (N/A) |
73.87 (228.74) |
209.65% | Details | |
| 3/27/2019 | Xencor, Inc. | XNCR | New Coverage | Buy (N/A) |
30.83 (11.32) |
-63.28% | Details | |
| 3/27/2019 | Gritstone Oncology | GRTS | New Coverage | Buy (N/A) |
10.93 (0.03) |
-99.73% | Details | |
| 3/27/2019 | Neon Therapeutics | NTGN | New Coverage | Buy (N/A) |
5.17 (3.07) |
-40.62% | Details |
